The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 Fibroblasts
Abstract
The v- abl oncogene of the Abelson murine leukemia virus (A-MuLV) is known to efficiently transform NIH/3T3 fibroblasts in vitro and to cause an acute lymphosarcoma in susceptible murine hosts. The role of its relative, the bcr / abl gene product, in the etiology of human chronic myelogenous leukemia (CML) remains speculative. To assess the transforming properties of the bcr / abl gene product, complementary DNA clones encoding the CML-specific P210 bcr / abl protein were expressed in NIH/3T3 fibroblasts. In contrast to the v- abl oncogene product P160, the P210 bcr / abl gene product did not transform NIH/3T3 cells. Cell lines were isolated that expressed high levels of the P210 bcr / abl protein but were morphologically normal. During the course of these experiments, a transforming recombinant of bcr / abl was isolated which fuses gag determinants derived from helper virus to the NH 2 -terminus of the bcr / abl protein. This suggests that a property of viral gag sequences, probably myristylation-dependent membrane localization, must be provided to bcr / abl for it to transform fibroblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Cited by
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
Self-citationThe molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 572
Self-citationInduction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher, M. A., McLaughlin, J., Witte, O. N., & Rosenberg, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6649 · Cited by 514
Self-citationKelly, L. M., Liu, Q., Kutok, J. L., Williams, I. R., Boulton, C. L., & Gilliland, D. G. (2002) · Blood · doi:10.1182/blood.v99.1.310 · Cited by 487
Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts
Housey, G. M., Johnson, M. D., Wendy Hsiao, W. L., O'Brian, C. A., Murphy, J. P., Kirschmeier, P., & Bernard Weinstein, I. (1988) · Cell · doi:10.1016/s0092-8674(88)80027-8 · Cited by 478
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
White, D. L., Saunders, V. A., Dang, P., Engler, J., Zannettino, A. C. W., Cambareri, A. C., Quinn, S. R., Manley, P. W., & Hughes, T. P. (2006) · Blood · doi:10.1182/blood-2005-11-4687 · Cited by 435
Weisberg, E., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.11.3498 · Cited by 401
The BCR-ABL Story: Bench to Bedside and Back
Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 399
Self-citationMuller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
Self-citationMolecular Genetics of Acute Lymphoblastic Leukemia
Armstrong, S. A., & Look, A. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.047 · Cited by 362
Integrins, Oncogenes, and Anchorage Independence
Schwartz, M. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.575 · Cited by 336
McWhirter, J. R., & Wang, J. Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05797.x · Cited by 317
Protein tyrosine kinases and cancer
Kolibaba, K. S., & Druker, B. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00022-x · Cited by 291
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson, P., & Baltimore, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03397.x · Cited by 278
Self-citationSchultz, A. M., Henderson, L. E., & Oroszlan, S. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.003143 · Cited by 252
BCR/ABL induces multiple abnormalities of cytoskeletal function
Salgia, R., Li, J. L., Ewaniuk, D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B., & Griffin, J. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119520 · Cited by 147
Metadata
- Authors
- Daley, G. Q., McLaughlin, J., Witte, O. N., & Baltimore, D.
- Venue
- Science
- Published
- 1987-07-31
- Volume
- 237
- Issue
- 4814
- Pages
- 532-535
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1994954403
- Cited by
- 172
- References
- 1
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.